目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Non-Clinical
4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Method Development & Validation
4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Extractable & Leachable
4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis
5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Competitive Scenario
6.4.10.3. Regulatory Framework
6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Competitive Scenario
6.4.11.3. Regulatory Framework
6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Competitive Scenario
6.4.12.3. Regulatory Framework
6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Competitive Scenario
6.4.13.3. Regulatory Framework
6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Competitive Scenario
6.4.14.3. Regulatory Framework
6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Competitive Scenario
6.4.15.3. Regulatory Framework
6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Competitive Scenario
6.4.16.3. Regulatory Framework
6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Thailand
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. South Korea
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Australia
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Share/Assessment Analysis, 2024
7.3. Company Profiles
7.3.1. SGS Société Générale de Surveillance SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Worldwide Clinical Trials
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Sofpromed
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. ClinChoice
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Evotec
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Eurofins Scientific
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. KYMOS Group
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. ViviaBiotech S.L.
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. GalChimia
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. TCI Laboratories
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Cotecna (NEOTRON SpA,)
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Tentamus
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Enzymlogic
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Pharmbiotest
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. UNIFARM - Research Centre
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. ANAPHARM EUROPE, S.L.U
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives

List of Tables
Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key Country Dynamics
Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key Country Dynamics
Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key Country Dynamics
Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key Country Dynamics
Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key Country Dynamics
Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key Country Dynamics
Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key Country Dynamics
Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key Country Dynamics
Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key Country Dynamics
Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key Country Dynamics
Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key Country Dynamics
Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key Country Dynamics
Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key Country Dynamics
Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key Country Dynamics
Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key Country Dynamics
Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key Country Dynamics
Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key Country Dynamics
Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key Country Dynamics
Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key Country Dynamics
Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key Country Dynamics
Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key Country Dynamics
Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key Country Dynamics
Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key Country Dynamics
Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key Country Dynamics
Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key Country Dynamics
Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key Country Dynamics
Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key Country Dynamics
Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key Country Dynamics
Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 103 Key Country Dynamics
Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key Country Dynamics
Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key company categorization
Fig. 108 Service heat map analysis
Fig. 109 Strategic framework